- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Camrelizumab and Apatinib
Total 271521 results
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Jiangxi Provincial Cancer HospitalRecruitingTriple-Negative Breast CancerChina
-
Wuhan UniversityRecruiting
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Spain, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Puerto Rico, Singapore, South Africa, Taiwan, United Kingdom, Australia, France, Philippines, Sweden, Thailand, Russian Federation, China, Poland, Finland, Isra... and more
-
Hunan Cancer HospitalSuzhou Sheng Diya Biomedical Co., Ltd.Active, not recruitingAdenocarcinoma of the LungChina
-
Newcastle UniversityBristol-Myers Squibb; Institute of Cancer Research, United Kingdom; Newcastle-upon-Tyne... and other collaboratorsCompletedMyeloid Leukemia, Chronic, Chronic PhaseUnited Kingdom
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicGermany, India, Japan, Korea, Republic of, Turkey, Chile, China, Spain, Australia, France, Poland, Mexico, Colombia, Belgium, Austria, Italy, Peru, Greece, Brazil, Czech Republic, Hungary, Russian Federation, Netherlands, Argentina, Den... and more
-
Huazhong University of Science and TechnologyNot yet recruitingAdvanced or Metastatic EP-NECChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruitingEsophageal Squamous Cell Carcinoma | Progression to PD-1 AntibodyChina
-
Wuhan Union Hospital, ChinaActive, not recruitingRectal Cancer | Radiotherapy | ImmunotherapyChina
-
wang shusenRecruitingAdvanced HER2 Negative Breast Carcinoma HRD+Breast CancerChina
-
Peking University Cancer Hospital & InstituteRecruiting
-
Nanfang Hospital of Southern Medical UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Peking University First HospitalNot yet recruitingImmunotherapy | SBRT | Bulky Tumor
-
Peking University Third HospitalNot yet recruitingOvarian Clear Cell Carcinoma
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma
-
Peking University People's HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Enrolling by invitationGermline BRCA-mutated HER2-negative Breast CancerChina
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Guangdong Association of Clinical TrialsNot yet recruitingNon-small Cell Lung Cancer
-
Beijing Sanbo Brain HospitalRecruitingPrimary Central Nervous System LymphomaChina
-
Guangdong Association of Clinical TrialsUnknown
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
PfizerCompleted
-
Bristol-Myers SquibbCompletedLeukemiaGermany, Italy, Korea, Republic of, Sweden, Thailand, United States, Australia, France, Poland, Switzerland, Spain, Ireland, Peru, Brazil, South Africa, Canada, Argentina, Hungary, Finland, Israel, Norway, Russian Federation, United... and more
-
Elevar TherapeuticsCompletedAdenoid Cystic CarcinomaUnited States, Korea, Republic of
-
Shanghai Jiao Tong University Affiliated Sixth...UnknownSoft Tissue Sarcoma
-
UNC Lineberger Comprehensive Cancer CenterCompletedChronic Myeloid Leukemia | Chronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | CML - Philadelphia Chromosome | CML (Chronic Myelogenous LeukemiaUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Oslo University HospitalThe Research Council of NorwayCompleted
-
Peking Union Medical College HospitalRecruitingEfficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GCChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedBreast Cancer | Triple Negative Breast CancerChina
-
Tianjin Medical University Cancer Institute and...Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HER2 Negative Breast Carcinoma | HRD+Breast CancerChina
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingLiver Transplantation | Hepatocellular CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNasopharyngeal CarcinomaChina
-
Wuhan Union Hospital, ChinaWithdrawnColorectal Cancer | Chemotherapy | Angiogenesis
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
Fudan UniversityNot yet recruitingColorectal CancerChina
-
Fuzhou General HospitalRecruitingEsophageal Squamous Cell CarcinomasChina
-
Masaryk UniversityActive, not recruitingChronic Myeloid Leukemia, Chronic Phase | Withdrawal;DrugCzechia
-
Shoucheng MaUnknownColorectal NeoplasmsChina
-
Shanghai Jiao Tong University School of MedicineCompletedOral Cancer | VEGFR2 Inhibitor | Programmed Cell Death 1 Inhibitor | Inductive TherapyChina
-
Henan Cancer HospitalRecruitingAdvanced Gastric AdenocarcinomaChina